STATE STREET CORP - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 115 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$1,404,000
-2.2%
12,418
-13.4%
0.00%
Q1 2017$1,436,000
+4.4%
14,337
+12.0%
0.00%
Q4 2016$1,375,000
-8.1%
12,796
+6.4%
0.00%
Q3 2016$1,497,000
+31.4%
12,028
+12.4%
0.00%
Q2 2016$1,139,000
+78.5%
10,704
+92.0%
0.00%
Q1 2016$638,000
-28.1%
5,575
-10.5%
0.00%
Q4 2015$887,0006,2290.00%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Ariose Capital Management Ltd 88,655$10,149,0009.57%
WARBURG PINCUS LLC 4,087,200$467,903,0008.91%
RUDMAN ERROL M 64,001$7,327,0004.96%
INDUS CAPITAL PARTNERS, LLC 378,518$43,333,0004.22%
OBERWEIS ASSET MANAGEMENT INC/ 90,105$10,315,0002.98%
Ativo Capital Management LLC 85,623$9,802,0002.66%
Sensato Investors LLC 113,296$12,970,0002.31%
Cormorant Asset Management, LP 111,500$12,765,0001.92%
BARING ASSET MANAGEMENT Ltd 128,784$14,743,0001.23%
Visium Asset Management, LP 484,619$55,479,0000.94%
View complete list of CHINA BIOLOGIC PRODS INC shareholders